At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02575 XUANZHUBIO-B
Closed 12-23 16:08:07
70.750
+0.500
+0.71%
High71.050
Low69.100
Vol334.57K
Open69.100
D1 Closing70.250
Amplitude2.78%
Mkt Cap36.64B
Tradable Cap11.37B
Total Shares517.95M
T/O23.36M
T/O Rate0.21%
Tradable Shares160.70M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
HK Movers | HK's Biotech Shares Soar. TransThera up 19%; JOINN up 11%; Xuanzhu Bio up 6%
HK Stock Movement | XUANZHUBIO-B (02575) Surges Over 20% to New High as Xuan Yuening Enters National Reimbursement List and Two Oncology Products Approved Within the Year
HK Stock Movement | XUANZHUBIO-B (02575) Rises Nearly 3% as Self-Developed Innovative Drug Xuan Yuening® Included in 2025 National Reimbursement Drug List for the First Time
Xuanzhu Technology Co., Ltd. is an innovative pharmaceutical company with a global perspective, rooted in China. It focuses on the fields of major diseases such as digestion, cancer, and non-alcoholic steatohepatitis, and is committed to continuously developing and commercializing Class 1 new drugs with core independent intellectual property rights to solve clinically unmet treatment needs. The company is an innovative pharmaceutical company with a global perspective, rooted in China.